Autologous HSCT Improves Long-Term Survival Autologous HSCT Improves Long-Term Survival
Patients with rapidly progressive systemic sclerosis could find long-term mortality benefits from autologous hematopoietic stem cell transplantation.Arthritis Research & Therapy
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news
More News: Arthritis | Health | Rheumatology | Scleroderma | Stem Cell Therapy | Stem Cells | Transplants